|
|
Volumn 93, Issue 8, 2006, Pages 604-606
|
|
Gallbladder cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CA 19-9 ANTIGEN;
CARCINOEMBRYONIC ANTIGEN;
CISPLATIN;
GEMCITABINE;
HEAVY METAL;
CANCER CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER RISK;
CANCER STAGING;
CANCER SURGERY;
CANCER SURVIVAL;
CARCINOGENESIS;
CHOLECYSTECTOMY;
CONFERENCE PAPER;
GALLBLADDER CANCER;
GALLSTONE;
HUMAN;
LOWEST INCOME GROUP;
MORBIDITY;
MORTALITY;
PREVALENCE;
PRIORITY JOURNAL;
PROGNOSIS;
TREATMENT PLANNING;
CHOLECYSTECTOMY, LAPAROSCOPIC;
COMBINED MODALITY THERAPY;
FEMALE;
GALLBLADDER NEOPLASMS;
GALLSTONES;
HUMANS;
INDIA;
INFECTION;
MAGNETIC RESONANCE IMAGING;
MALE;
POSITRON-EMISSION TOMOGRAPHY;
SURVIVAL RATE;
TOMOGRAPHY, X-RAY COMPUTED;
|
|
EID: 33744964855
PISSN: 00224790
EISSN: 10969098
Source Type: Journal
DOI: 10.1002/jso.20524 Document Type: Conference Paper |
|
Times cited : (14)
|
|
References (0)
|
